|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2009-12-18
|
|
pubmed:abstractText |
Medical castration with long-acting GnRH-agonist (GnRHa) is a well-established treatment for metastatic prostate cancer. Our aim was to explore the relationships between FSH, inhibin B, anti-Mullerian hormone (AMH), and testosterone during treatment with an implant releasing GnRHa.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1479-683X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
162
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
177-81
|
|
pubmed:meshHeading |
pubmed-meshheading:19820037-Aged,
pubmed-meshheading:19820037-Aged, 80 and over,
pubmed-meshheading:19820037-Anti-Mullerian Hormone,
pubmed-meshheading:19820037-Follicle Stimulating Hormone,
pubmed-meshheading:19820037-Gonadotropin-Releasing Hormone,
pubmed-meshheading:19820037-Humans,
pubmed-meshheading:19820037-Inhibins,
pubmed-meshheading:19820037-Long-Term Care,
pubmed-meshheading:19820037-Male,
pubmed-meshheading:19820037-Prostatic Neoplasms,
pubmed-meshheading:19820037-Retrospective Studies,
pubmed-meshheading:19820037-Testosterone,
pubmed-meshheading:19820037-Time Factors
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Relationships between FSH, inhibin B, anti-Mullerian hormone, and testosterone during long-term treatment with the GnRH-agonist histrelin in patients with prostate cancer.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Shaare-Zedek Medical Center, The Hebrew University, Jerusalem, Israel. gevat@szmc.org.il
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
